Harmony Biosciences Holdings (HRMY) stock forecast — our track record

Lyra published 7 HRMY stock forecasts beginning July 1, 2025. Every prediction covered the short term (0 to 3 months), and every outcome window was closed by September 23, 2026. Each forecast was made public before its result was known, so the record includes the calls as originally issued rather than selections made after the fact. The forecasts all used the same horizon, so there was no comparison across short, medium, and long periods.

Four of the 7 forecasts reached their targets. Three received partial credit, and none of them missed. The average success score was 78.6%. For the short-term calls, which accounted for all 7 forecasts, the average score was also 78.6%. The scoring therefore showed more full target results than partial results, while every published call earned at least some credit.

The best call was published on October 23, 2025. It predicted 34% growth, and the stock rose as much as 42%. The target was reached in 42 days, and the call earned a 100% success score. The worst call was published on July 7, 2025. It predicted 30% growth, while the stock rose as much as 17.8% during the outcome window. It did not reach the target and received a 50% success score. Overall, the track record was positive, with 4 targets reached, three partial results, and no misses.